According to X4 Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.85. In 2022 the company made an earnings per share (EPS) of -$3.33 an increase over its 2021 EPS that were of -$7.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.71 | -48.71% |
2022 | -$3.33 | -53.71% |
2021 | -$7.20 | 30.32% |
2020 | -$5.52 | -67.61% |
2019 | -$17.05 | -36.99% |
2018 | -$27.06 | -46.69% |
2017 | -$50.76 |